Dose proportionality and pharmacokinetics of extended-release (OROS®) hydromorphone: A phase 1, open-label, randomized, crossover study in healthy Taiwanese subjects

Author(s):

Joris Vandenbossche ◽

Henry M. Richards ◽

Chih Cherng Lu ◽

Ute Richarz

Keyword(s):

Crossover Study ◽

Extended Release ◽

Phase 1 ◽

Dose Proportionality ◽

Open Label ◽

A Phase 1, Open-Label, Randomized, Crossover Study Evaluating the Bioavailability of TAS-102 (Trifluridine/Tipiracil) Tablets Relative to an Oral Solution Containing Equivalent Amounts of Trifluridine and Tipiracil

The Journal of Clinical Pharmacology ◽

10.1002/jcph.856 ◽

2017 ◽

Vol 57 (6) ◽

pp. 751-759 ◽

Author(s):

Carlos R. Becerra ◽

Kenichiro Yoshida ◽

Hirokazu Mizuguchi ◽

Manish Patel ◽

Daniel Von Hoff

Keyword(s):

Crossover Study ◽

Phase 1 ◽

Oral Solution ◽

Open Label ◽

Implementation of a Reference-Scaled Average Bioequivalence Approach for Highly Variable Acetylsalicylic Acid in Fixed-Dose Combination with Clopidogrel Versus Enteric Aspirin in Chinese Subjects Under Fasting Conditions: A Phase 1, Open-Label, Randomized, Crossover Study

Advances in Therapy ◽

10.1007/s12325-020-01369-z ◽

2020 ◽

Vol 37 (6) ◽

pp. 2696-2709

Author(s):

Lu Wang ◽

Yujing Di ◽

Tingting Guo ◽

Jeffrey E. Ming ◽

Fangyuan Kong ◽

...

Keyword(s):

Acetylsalicylic Acid ◽

Crossover Study ◽

Phase 1 ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Open Label ◽

Average Bioequivalence ◽

Dose Combination ◽

Randomized Crossover Study ◽

Chinese Subjects

Pharmacokinetics and Dose-Proportionality of Oxymorphone Extended Release and Its Metabolites: Results of a Randomized Crossover Study

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1592/phco.24.5.468.33347 ◽

2004 ◽

Vol 24 (4) ◽

pp. 468-476 ◽

Cited By ~ 49

Author(s):

Michael P. Adams ◽

Harry Ahdieh

Keyword(s):

Crossover Study ◽

Extended Release ◽

Dose Proportionality ◽

An open-label, randomized, crossover study of the relative bioavailability of desvenlafaxine after oral administration of extended-release venlafaxine and sustained-release desvenlafaxine succinate in healthy subjects

Clinical Pharmacology & Therapeutics ◽

10.1016/j.clpt.2004.12.222 ◽

2005 ◽

Vol 77 (2) ◽

pp. P86-P86 ◽

Author(s):

A NICHOLS ◽

A PATAT ◽

S BAIRDBELLAIRE ◽

J BEHRLE ◽

P CHRETIEN

Keyword(s):

Sustained Release ◽

Oral Administration ◽

Crossover Study ◽

Healthy Subjects ◽

Extended Release ◽

Relative Bioavailability ◽

Open Label ◽

Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study

Advances in Therapy ◽

10.1007/s12325-016-0374-x ◽

2016 ◽

Vol 33 (9) ◽

pp. 1519-1535 ◽

Cited By ~ 15

Author(s):

Yuuichi Sakurai ◽

Madoka Shiino ◽

Hiroyuki Okamoto ◽

Akira Nishimura ◽

Koki Nakamura ◽

...

Keyword(s):

Crossover Study ◽

Triple Therapy ◽

Phase 1 ◽

Open Label ◽

Faculty Opinions recommendation of Sacral neuromodulation in children with urinary and fecal incontinence: a multicenter, open label, randomized, crossover study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3749956.4297082 ◽

2010 ◽

Author(s):

Carlo Di Lorenzo

Keyword(s):

Fecal Incontinence ◽

Crossover Study ◽

Sacral Neuromodulation ◽

Open Label ◽

An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naive to phosphodiesterase 5 inhibitor therapy

BJU International ◽

10.1111/j.1464-410x.2005.05892.x ◽

2005 ◽

Vol 96 (9) ◽

pp. 1323-1332 ◽

Cited By ~ 65

Author(s):

Ian Eardley ◽

Vincenzo Mirone ◽

Francesco Montorsi ◽

David Ralph ◽

Philip Kell ◽

...

Keyword(s):

Erectile Dysfunction ◽

Crossover Study ◽

Inhibitor Therapy ◽

Sildenafil Citrate ◽

Open Label ◽

Phosphodiesterase 5 Inhibitor ◽

Phosphodiesterase 5 ◽

Pharmacokinetics and Safety of Coadministered Oseltamivir and Rimantadine in Healthy Volunteers: An Open-Label, Multiple-Dose, Randomized, Crossover Study

The Journal of Clinical Pharmacology ◽

10.1177/0091270011412960 ◽

2012 ◽

Vol 52 (8) ◽

pp. 1255-1264 ◽

Author(s):

Georgina Cirrincione-Dall ◽

Barbara J. Brennan ◽

Rosa M. Ballester-Sanchis ◽

Mercidita T. Navarro ◽

Brian E. Davies

Keyword(s):

Crossover Study ◽

Healthy Volunteers ◽

Multiple Dose ◽

Open Label ◽

A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine

Advances in Therapy ◽

10.1007/s12325-019-01022-4 ◽

2019 ◽

Vol 36 (9) ◽

pp. 2394-2401

Author(s):

Eric R. Kinzler ◽

Carmela Pantaleon ◽

Matthew Iverson ◽

Stefan Aigner

Keyword(s):

Crossover Study ◽

Extended Release ◽

Effect Of Food ◽

A randomized crossover study to assess the pharmacokinetics of a novel amphetamine extended-release orally disintegrating tablet in healthy adults

Postgraduate Medicine ◽

10.1080/00325481.2016.1216716 ◽

2016 ◽

Vol 128 (7) ◽

pp. 648-655 ◽

Cited By ~ 8

Author(s):

Jeffrey G. Stark ◽

Dorothy Engelking ◽

Russ McMahen ◽

Carolyn Sikes

Keyword(s):

Crossover Study ◽

Extended Release ◽

Healthy Adults ◽

Orally Disintegrating Tablet ◽